Fingerprint
Dive into the research topics of 'A Phase i Study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A Phase i Study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer
Balazs Halmos, Yuxia Jia, Joseph A. Bokar, Pingfu Fu, David J. Adelstein, Rosalyn Juergens, Mary Beth Rodal, Afshin Dowlati
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations